Life ScienceCompany
AMAG Pharmaceuticals M&A Summary
AMAG Pharmaceuticals has acquired 3 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
AMAG Pharmaceuticals’ largest acquisition to date was in 2015, when it acquired Cord Blood Registry for $700M. It’s largest disclosed sale occurred in 2020, when it sold AMAG Pharmaceuticals - INTRAROSA Rights to Millicent Pharma for $125M. AMAG Pharmaceuticals has acquired in 3 different US states. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).
AMAG Pharmaceuticals Ownership
Who owns AMAG Pharmaceuticals?
AMAG Pharmaceuticals is owned by Covis Pharma Sàrl. It was acquired on November 16, 2020.
AMAG Pharmaceuticals Business Overview
Where is AMAG Pharmaceuticals headquartered?
AMAG Pharmaceuticals is headquartered in Waltham, Massachusetts.
What is AMAG Pharmaceuticals’ revenue?
AMAG Pharmaceuticals disclosed revenue of 328M USD for 2019 and 474M USD for 2018.
How many employees does AMAG Pharmaceuticals have?
AMAG Pharmaceuticals has 440 employees.
What sector is AMAG Pharmaceuticals in?
AMAG Pharmaceuticals is a life science company.
When was AMAG Pharmaceuticals founded?
AMAG Pharmaceuticals was founded in 1981.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 7
Unlimited Searches
